Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

EXPONENT INC
Next earnings Jul 29, 2026 · consensus $0.56 EPS, $150M rev
Last earnings +1.1% on 2026-04-30
Healthy net margin (18.2%).
Middling fundamentals and a rich price (~60% above fair value) leave little margin of safety — a wait-and-see.
Sources: SEC EDGAR (CIK 0000851520, latest 10-Q filed 2026-05-08) · EODHD · as of 6/22/2026, 12:10:20 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
EXPONENT INC shows $582M in FY2026 revenue (+4.2% YoY), a 18.2% net margin, and 27.2% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | $466M | $513M | $537M | $559M | $582M |
| Gross profit | — | — | — | — | — |
| Operating income | $109M | $141M | $111M | $120M | $120M |
| Net income | $101M | $102M | $100M | $109M | $106M |
| Diluted EPS | $1.90 | $1.96 | $1.94 | $2.11 | $2.07 |
| Net margin | 21.7% | 19.9% | 18.7% | 19.5% | 18.2% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1483 tracked peers · median
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
Last 90 days: 0 open-market buys · 4 sales
| 2026-06-15 | Corrigan Catherine President & CEO | Exercise | 3.23K @ $25.41 | $81.9K |
| 2026-06-15 | Corrigan Catherine President & CEO | Sell | 2.33K @ $57.13 | $133K |
| 2026-06-15 | Corrigan Catherine President & CEO | Exercise | 2.38K @ $29.05 | $69.1K |
| 2026-06-15 | Corrigan Catherine President & CEO | Sell | 1.79K @ $57.13 | $102K |
| 2026-06-03 | Lindstrom Carol Director | Exercise | 2.01K | |
| 2026-06-03 | Brown George H. Director | Exercise | 2.01K | |
| 2026-06-03 | RICHARDSON KAREN A Director | Exercise | 2.01K | |
| 2026-06-03 | Zumwalt Debra Director | Exercise | 2.01K | |
| 2026-06-03 | JOHNSTON PAUL R Director | Exercise | 2.01K | |
| 2026-05-26 | James Bradley A Group Vice President | Sell | 2.00K @ $57.47 | $115K |
| 2026-05-19 | Reiss Richard Group Vice President | Sell | 1.67K @ $58.65 | $98.1K |